Stratasys Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $551.1M-3.7% YoYTTM through 31 Dec 2025
Net Income -$104.3MTTM through 31 Dec 2025
Free Cash Flow -$7.4MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 41.2% |
| EBITDA Margin | -3.5% |
| Operating Margin | -13.2% |
| Net Margin | -18.9% |
Returns
-12.4%ROE
-9.7%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio3.57x
Net Debt-$244.5Mnet cash position
Cash & Equivalents$94.5M
Quality Metrics
Altman Z-Score-0.55
FCF Margin-1.3%
Rule of 401.7
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $551.1M
Diluted EPSFY2023: $-1.79
Dividend
No dividend
Capital Allocation
R&D Spend$77.3M
Capex Intensity2.2%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Product | $380.3M | -3.0% | |
| Service | $170.8M | -5.4% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.